CA Stock MarketDetailed Quotes
CTX Crescita Therapeutics Inc
- 0.510
- 0.0000.00%
15min DelayMarket Closed Jul 4 16:00 ET
9.91MMarket Cap-4250P/E (TTM)
0.000High0.000Low0Volume0.000Open0.510Pre Close0.00Turnover0.73052wk High0.00%Turnover Ratio19.44MShares0.36052wk Low-0.12EPS TTM8.70MFloat Cap2.000Historical HighLossP/E (Static)17.06MShs Float0.350Historical Low-0.1EPS LYR0.00%Amplitude--Dividend TTM0.55P/B1Lot Size--Div YieldTTM
Crescita Therapeutics Inc Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -7.24%9.53M | 13.92%9.39M | 13.92%9.39M | -6.68%10.02M | -2.63%10.23M | -12.49%10.28M | -27.30%8.24M | -27.30%8.24M | -12.24%10.74M | -19.73%10.5M |
| -Cash and cash equivalents | -7.24%9.53M | 13.92%9.39M | 13.92%9.39M | -6.68%10.02M | -2.63%10.23M | -12.49%10.28M | -27.30%8.24M | -27.30%8.24M | -12.24%10.74M | -19.73%10.5M |
| -Accounts receivable | -17.70%3.45M | -73.91%1.19M | -73.91%1.19M | -34.79%2.32M | 2.63%3.67M | 20.71%4.2M | 116.47%4.56M | 116.47%4.56M | 242.73%3.56M | 142.55%3.58M |
| Total current assets | -9.97%18.37M | -9.89%18.49M | -9.89%18.49M | -6.16%18.81M | -0.63%19.61M | -2.23%20.41M | 2.11%20.52M | 2.11%20.52M | 5.43%20.05M | 2.31%19.73M |
| Non current assets | ||||||||||
| -Accumulated depreciation | ---- | -9.48%-2.61M | -9.48%-2.61M | ---- | ---- | ---- | -9.66%-2.39M | -9.66%-2.39M | ---- | ---- |
| -Long term equity investment | -36.41%702K | -32.53%815K | -32.53%815K | -28.01%892K | -25.17%999K | -22.80%1.1M | -20.79%1.21M | -20.79%1.21M | -23.42%1.24M | -21.93%1.34M |
| Non current note receivables | ---- | --0 | --0 | --196K | --196K | --289K | --455K | --455K | ---- | ---- |
| -Goodwill | -32.97%1.78M | -30.46%1.99M | -30.46%1.99M | -28.33%2.21M | -26.46%2.43M | -24.82%2.65M | -23.37%2.87M | -23.37%2.87M | -22.06%3.09M | -20.92%3.3M |
| Regulatory assets | -17.47%3.51M | -55.52%2.78M | -55.52%2.78M | -33.41%2.48M | 2.72%3.78M | 20.38%4.25M | 66.51%6.24M | 66.51%6.24M | 172.59%3.73M | 90.88%3.68M |
| Non current deferred assets | -7.63%1.45M | -5.86%1.48M | -5.86%1.48M | 2.05%1.49M | 0.73%1.52M | -0.19%1.57M | -5.65%1.57M | -5.65%1.57M | -16.14%1.46M | -13.66%1.51M |
| Total assets | ---- | -79.21%21K | -79.21%21K | ---- | ---- | ---- | -30.34%101K | -30.34%101K | ---- | ---- |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Current debt and capital lease obligation | 8.29%444K | 8.40%439K | 8.40%439K | 10.29%418K | 10.40%414K | -69.83%410K | -69.84%405K | -69.84%405K | -71.46%379K | -71.31%375K |
| -Current capital lease obligation | 8.29%444K | 8.40%439K | 8.40%439K | 10.29%418K | 10.40%414K | 10.51%410K | 10.35%405K | 10.35%405K | 4.41%379K | 6.23%375K |
| -Total tax payable | -34.79%804K | -31.48%912K | -31.48%912K | -26.53%1.03M | -24.15%1.13M | -22.11%1.23M | -20.39%1.33M | -20.39%1.33M | -21.71%1.41M | -20.44%1.5M |
| Current liabilities | -11.08%5.12M | -19.70%4.86M | -19.70%4.86M | -17.48%5.22M | -24.58%4.8M | -26.24%5.76M | -9.93%6.06M | -9.93%6.06M | -5.83%6.33M | 9.83%6.37M |
| Non current liabilities | ||||||||||
| -Long term debt | -36.41%702K | -32.53%815K | -32.53%815K | -28.01%892K | -25.17%999K | -22.80%1.1M | -20.79%1.21M | -20.79%1.21M | -23.42%1.24M | -21.93%1.34M |
| Non current accrued expenses | -21.94%1.68M | -20.02%1.85M | -20.02%1.85M | -21.02%1.86M | -20.26%2M | -17.21%2.15M | -10.40%2.31M | -10.40%2.31M | -4.76%2.36M | -1.03%2.5M |
| Total non current liabilities | -15.26%5.93M | -21.82%5.78M | -21.82%5.78M | -19.12%6.26M | -24.50%5.94M | -25.55%6.99M | -12.02%7.39M | -12.02%7.39M | -9.18%7.74M | 2.42%7.87M |
| Shareholders'equity | ||||||||||
| Share capital | -4.29%53.89M | -3.49%54.34M | -3.49%54.34M | -2.23%55.35M | -1.88%56.3M | -2.53%56.3M | -3.06%56.3M | -3.06%56.3M | -2.93%56.61M | -1.21%57.38M |
| -common stock | -4.29%53.89M | -3.49%54.34M | -3.49%54.34M | -2.23%55.35M | -1.88%56.3M | -2.53%56.3M | -3.06%56.3M | -3.06%56.3M | -2.93%56.61M | -1.21%57.38M |
| Additional paid-in capital | 47.92%6.36M | 39.45%5.96M | 39.45%5.96M | 26.95%5.08M | 27.95%4.32M | 40.81%4.3M | 54.24%4.27M | 54.24%4.27M | 57.04%4M | 38.23%3.38M |
| Gains losses not affecting retained earnings | -0.88%1.12M | -0.88%1.12M | -0.88%1.12M | -1.65%1.13M | -1.73%1.13M | -1.74%1.13M | -1.22%1.13M | -1.22%1.13M | 9.51%1.15M | 9.60%1.15M |
| Other equity interest | -36.17%270K | ---- | ---- | -28.93%420K | -55.56%272K | -33.91%423K | ---- | ---- | --591K | --612K |
| Noncontrolling interests | -0.29%349K | 4.68%358K | 4.68%358K | 19.48%368K | 16.18%359K | 7.36%350K | 1.18%342K | 1.18%342K | -6.67%308K | --309K |
| Total equity | -13.55%24.07M | -13.64%24.6M | -13.64%24.6M | -8.44%25.37M | -4.55%26.53M | -5.35%27.84M | -1.52%28.48M | -1.52%28.48M | -1.11%27.71M | 0.19%27.79M |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
%Chg